148 related articles for article (PubMed ID: 21248444)
1. Role of RT-PCR and FISH in diagnosis and monitoring of acute promyelocytic leukemia.
Polampalli S; Choughule A; Prabhash K; Amare P; Baisane C; Kabre S; Mahadik S; Shinde S; Nair R; Banavali S
Indian J Cancer; 2011; 48(1):60-7. PubMed ID: 21248444
[TBL] [Abstract][Full Text] [Related]
2. Identification of PML-RARA rearrangement by RT-PCR and sequencing in an acute promyelocytic leukemia without t(15;17) on G-banding and FISH.
Han JY; Kim KE; Kim KH; Park JI; Kim JS
Leuk Res; 2007 Feb; 31(2):239-43. PubMed ID: 16797070
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
Gau JP; Young JH; Lin TH; Yang YS
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412
[TBL] [Abstract][Full Text] [Related]
4. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
[TBL] [Abstract][Full Text] [Related]
5. A new complex translocation t(5;17;15)(q11;q21;q22) in acute promyelocytic leukemia.
Abe S; Ishikawa I; Harigae H; Sugawara T
Cancer Genet Cytogenet; 2008 Jul; 184(1):44-7. PubMed ID: 18558288
[TBL] [Abstract][Full Text] [Related]
6. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
[TBL] [Abstract][Full Text] [Related]
7. Minimal residual disease in acute promyelocytic leukemia.
Weil SC
Clin Lab Med; 2000 Mar; 20(1):105-17, ix. PubMed ID: 10702899
[TBL] [Abstract][Full Text] [Related]
8. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
Naeem M; Harrison K; Barton K; Nand S; Alkan S
Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
[TBL] [Abstract][Full Text] [Related]
9. A complex, four-way variant t(15;17) in acute promyelocytic leukemia.
Yoo SJ; Seo EJ; Lee JH; Seo YH; Park PW; Ahn JY
Cancer Genet Cytogenet; 2006 Jun; 167(2):168-71. PubMed ID: 16737919
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
[TBL] [Abstract][Full Text] [Related]
11. Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA).
Wang ZY; Chen Z; Huang W; Li XS; Lu JX; Huang LA; Zhang FQ; Gu LJ; Ouyang RR; Chen SJ
Blood Cells; 1993; 19(3):633-41; discussion 642-7. PubMed ID: 8018944
[TBL] [Abstract][Full Text] [Related]
12. Acute promyelocytic leukemia: a paradigm for differentiation therapy.
Grimwade D; Mistry AR; Solomon E; Guidez F
Cancer Treat Res; 2010; 145():219-35. PubMed ID: 20306254
[TBL] [Abstract][Full Text] [Related]
13. Derivative (7)t(7;8): The sole karyotype abnormality in acute promyelocytic leukemia with PML/RARA rearrangement identified by RT-PCR and sequence analysis.
Wang Y; Fang M; Jing Y; Li J; Jiang F; Wang Y
Leuk Res; 2009 Jul; 33(7):e55-8. PubMed ID: 19162322
[No Abstract] [Full Text] [Related]
14. Molecular cytogenetics of the acute promyelocytic leukemia-derived cell line NB4 and of four all-trans retinoic acid-resistant subclones.
Mozziconacci MJ; Rosenauer A; Restouin A; Fanelli M; Shao W; Fernandez F; Toiron Y; Viscardi J; Gambacorti-Passerini C; Miller WH; Lafage-Pochitaloff M
Genes Chromosomes Cancer; 2002 Nov; 35(3):261-70. PubMed ID: 12353268
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of distinct PML-RAR-alpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction.
Chen SJ; Chen Z; Chen A; Tong JH; Dong S; Wang ZY; Waxman S; Zelent A
Oncogene; 1992 Jun; 7(6):1223-32. PubMed ID: 1375719
[TBL] [Abstract][Full Text] [Related]
16. Isochromosome for derivative 17q in acute promyelocytic leukemia: evidence for two copies of PML-RARA and favorable response to all-trans-retinoic acid therapy.
Park JP; Fairweather RB; Mohandas TK
Genes Chromosomes Cancer; 1997 Feb; 18(2):151-3. PubMed ID: 9115966
[No Abstract] [Full Text] [Related]
17. A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia.
García-Casado Z; Cervera J; Valencia A; Pajuelo JC; Mena-Duran AV; Barragán E; Bolufer P; Sanz MA
Cancer Genet Cytogenet; 2006 Jul; 168(1):73-6. PubMed ID: 16772124
[TBL] [Abstract][Full Text] [Related]
18. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
[TBL] [Abstract][Full Text] [Related]
19. [New strategy for diagnosis and treatment of acute promyelocytic leukemia with t (15;17)].
Kubo K; Naoe T; Fukutani H; Ohno R
Rinsho Ketsueki; 1994 Mar; 35(3):250-5. PubMed ID: 8158844
[TBL] [Abstract][Full Text] [Related]
20. Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors.
Avvisati G; Lo Coco F; Mandelli F
Semin Hematol; 2001 Jan; 38(1):4-12. PubMed ID: 11172535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
